More than 60 percent of Vermont residents drink, a figure that’s nearly 10 percent higher than the U.S. average.

These days, mental health problems are on the rise, the California Health Collaborative reports. According to the Truth ...

Addiction and obesity share deep neurological roots. Can new treatments like GLP-1 drugs and MEAI help break the cycle?

For years, people taking GLP-1 type drugs (e.g., Ozempic, Wegovy) have noticed that the medicines didn’t just help them to ...

Alcohol use disorder (AUD) is a major global public health issue, affecting more than 28 million adults in the United States ...

Compared to the general population, individuals with incident hospital-based cannabis use disorder care have an increased risk of death.

There is a connection between alcohol and anxiety the day after you drink for many reasons, even if you’ve not been diagnosed ...

There are early and suggestive data that GLP-1 drugs reduce alcohol cravings. A large cohort of people with alcohol use ...

Using tariffs to get other countries to solve our drug crisis is at best ineffective and at worst disingenuous.

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing substance use disorders. Act 80 provides funding for the use of naltrexone, ...

There is initial evidence that low-dose semaglutide may reduce craving and drinking outcomes in individuals with alcohol-use disorder.

Lawmakers are hoping to expand and improve upon a 2015 law that offers grants to county jails treating inmates experiencing substance use disorders.